Cybin Inc.
Cybin Inc. (CYBN.NE) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CYBN.NE · as of Jun 8, 2026
Key Statistics
Explore Cybin Inc. Data
cybn.ne stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 3 · Buy rate: 100.0%
Competitors & Peers
cybn.ne competitorsCYBN.NE
CRRX.TO
DR.TO
EPRX.TO
FRX.TO
HBP.TOStock Performance
Full HistoryAbout Cybin Inc.
Cybin Inc. a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depress…
what is cybin inc. · cybn.ne stock overview · cybin inc. company profile · who is cybin inc. ceo · cybn.ne NEO · cybin inc. headquarters · cybin inc. business segments
About Stock Overview & Key Data
Cybin Inc. (CYBN.NE) is a Healthcare company in the Biotechnology industry, listed on NEO since Nov 10, 2020. As of the latest trading session, CYBN.NE stock price is $5.70, with a market capitalization of $138.0M. The stock has returned -50.35% over the past 12 months and -48.69% year-to-date.
According to 3 Wall Street analysts, the consensus rating for Cybin Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Cybin Inc. reported revenue of — and net income of -$113.1M. For detailed data — including Cybin Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Cybin Inc. (CYBN.NE) stock price is $5.70. The stock is traded on NEO under the ticker symbol CYBN.NE. The 52-week range is $5.70 – $15.27.